X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Intrommune's clinical stage oral mucosal therapy, INT301, for food allergies will combine its disease-modifying treatment through its peanut oral mucosal immunotherapy, with the rapid desensitization to allergens provided by Inimmune’s clinical stage proprietary immunotherapy.
Lead Product(s): INT301
Therapeutic Area: Immunology Product Name: INT301
Highest Development Status: Phase IProduct Type: Large molecule
Partner/Sponsor/Collaborator: Inimmune
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Collaboration January 08, 2024
Details:
INT301 is a novel peanut desensitization immunotherapy formulated in a fully-functioning toothpaste conveniently administered during a patient’s daily toothbrushing routine.
Lead Product(s): INT301
Therapeutic Area: Immunology Product Name: INT301
Highest Development Status: Phase IProduct Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable July 25, 2023
Details:
INT301 is a novel peanut desensitization immunotherapy formulated in a fully-functioning toothpaste conveniently administered during a patient’s daily toothbrushing routine.
Lead Product(s): INT301
Therapeutic Area: Immunology Product Name: INT301
Highest Development Status: Phase IProduct Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 26, 2022
Details:
INT301 is a novel peanut desensitization immunotherapy formulated as a fully-functioning toothpaste conveniently administered during a patient’s daily toothbrushing routine.
Lead Product(s): INT301
Therapeutic Area: Immunology Product Name: INT301
Highest Development Status: Phase IProduct Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 22, 2022
Details:
INT301 is a novel peanut desensitization immunotherapy formulated as a fully-functioning toothpaste and conveniently administered during a patient’s daily toothbrushing routine.
Lead Product(s): INT301
Therapeutic Area: Immunology Product Name: INT301
Highest Development Status: Phase IProduct Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 06, 2022
Details:
INT301 is a novel peanut desensitization immunotherapy met safety goals across four dose levels in cohort 1 patient treatment now ongoing in fully enrolled cohort 2 in patients with peanut allergy.
Lead Product(s): INT301
Therapeutic Area: Immunology Product Name: INT301
Highest Development Status: Phase IProduct Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable February 08, 2022
Details:
The presentation will focus on lead product INT301, Intrommune’s peanut allergy treatment administered daily through the brushing of teeth, and the oral mucosal immunotherapy (OMIT) platform upon which the treatment is based.
Lead Product(s): INT301
Therapeutic Area: Immunology Product Name: INT301
Highest Development Status: Phase IProduct Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable June 17, 2021
Details:
INT301 is an oral mucosal immunotherapy (OMIT) in development for the treatment of peanut allergies. INT301’s unique formulation is designed to desensitize an individual with peanut allergy using a toothpaste delivery system.
Lead Product(s): INT301
Therapeutic Area: Immunology Product Name: INT301
Highest Development Status: IND EnablingProduct Type: Large molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable February 04, 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
